They found that lncRNA GAS5 expression was suppressed when compared to the healthy control group, and that two lncRNAs (GAS5 (low expression) and SRA (high expression) could distinguish IPMN cases from the non-diseased control group (Table 2). The gene discussed is GAS5; the disease is pancreatic intraductal papillary-mucinous neoplasm.